Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Feb 14, 2025
by Keith Speights
Why Recursion Pharmaceuticals Stock Is Soaring Today

Feb 12, 2025
by Keith Speights
Why Gilead Sciences Stock Is Jumping Today

Feb 9, 2025
by Keith Speights
3 Dividend Stocks to Double Up on Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.